China Universal Asset Management »

Apogee Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $508k 8.7k 58.74
2024-06-30 $208k 5.3k 39.35
2024-03-31 $475k 7.2k 66.45
2023-12-31 $155k 5.6k 27.94

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
BlackRock
Driehaus Capital Management
Fairmount Funds Management
Perceptive Advisors
Vanguard Group
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners
Franklin Resources
Geode Capital Management

View all funds holding Apogee Therapeutics